| Theresa Lynn Gulla, OCCUPATIONAL THERAPY | |
|
1023 E Baltimore Pike Ste 303, Media, PA 19063-5126 | |
| (610) 449-1600 | |
| Not Available |
| Full Name | Theresa Lynn Gulla |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1023 E Baltimore Pike Ste 303, Media, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073185971 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OC017319 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Theresa Lynn Gulla, OCCUPATIONAL THERAPY 6700 Chestnut Hill Rd, Coopersburg, PA 18036-9710 Ph: (610) 762-5714 | Theresa Lynn Gulla, OCCUPATIONAL THERAPY 1023 E Baltimore Pike Ste 303, Media, PA 19063-5126 Ph: (610) 449-1600 |
News Archive
The surgical correction of adult spinal deformities often involves realigning the lower portion of the spine, or the 'lumbar' spine.
Amgen (Nasdaq: AMGN) today announced detailed results from the Phase 3 '181' trial evaluating Vectibix((R)) (panitumumab) in combination with FOLFIRI (an irinotecan based chemotherapy), as a second-line treatment for metastatic colorectal cancer (mCRC). In this trial, Vectibix significantly improved progression-free survival (PFS) in patients with KRAS wild-type mCRC.
Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar (sorafenib) tablets, Stivarga (regorafenib) tablets and the recently U.S. Food and Drug Administration approved product Xofigo (radium Ra 223 dichloride) injection will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31 – June 4, in Chicago, IL (USA).
Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, will present promising clinical data for CMX001 in a late-breaker poster session at the Infectious Diseases Society of America (IDSA) 48th Annual Meeting.
By employing optogenetics, a new field that uses genetically altered cells to respond to light, and a tandem unit cell (TCU) strategy, researchers at Stony Brook University have demonstrated a way to control cell excitation and contraction in cardiac muscle cells, the details of which are published in the early online edition of Circulation: Arrhythmia & Electrophysiology: "Stimulating Cardiac Muscle by Light: Cardiac Optogenetics by Cell Delivery."
› Verified 3 days ago
Stephanie Marie Cassidy, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 W Third St, Media, PA 19063 Phone: 215-870-8971 | |
Ms. Jennifer Santisi, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 538 Washington Ave, Media, PA 19063 Phone: 610-716-4729 | |
Dorothy Agnes Summers, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1400 N Providence Rd Ste 210, Media, PA 19063 Phone: 610-891-1636 | |
Renee Kathleen Staiber, OTR/L, ATP Occupational Therapist Medicare: Medicare Enrolled Practice Location: 311 E Baltimore Pike, Media, PA 19063 Phone: 610-892-8767 | |
Mitchell Ehrlich, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1023 E Baltimore Pike, Suite 303, Media, PA 19063 Phone: 610-891-1636 | |
Julia Wing, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 N Jackson St Ste 203, Media, PA 19063 Phone: 484-444-2285 |